Personalize My Medicine
Personalize My Medicine works to help bridge the information gap between the explosion in medical innovations and the researchers, doctors, and patients who want to apply this information to their work and life, thus placing patients at the center of medical advancements. The goal of Personalize My Medicine is to solve this problem by creating a patient-centered medicine approach, in which patients have better access to innovations and actively participate in making them available.
Condition Awareness & Advocacy
Here is a list of conditions this partner raises awareness and advocacy for:
Patient Worthy Posts on Rare Disease and Medication
ICYMI: Alecensa Exhibited Unprecedented Results for Patients with Early-Stage Lung Cancer
Over 50% of non-small cell lung cancer patients (NSCLC) will experience a recurrence after surgery. The cancer recurs even after adjuvant chemotherapy after major surgery.
Jardiance is Now FDA-Approved for Chronic Kidney Disease (CKD)
Previously, the FDA has approved Jardiance (empagliflozin) as a treatment option for adults with heart failure and to manage blood sugar in people ages
ABM-1310 Granted Fast Track Designation for Glioblastoma
In July 2023, the U.S. FDA granted Orphan Drug designation to ABM-1310, an investigational treatment option for people living with malignant gliomas such as
Strange Symptoms Lead to Diagnosis of Cushing’s Disease
Editor’s Note: We believe that patients are a key part of developing and leading the conversation in disease communities. Patient Worthy sometimes partners with reputable
The Rare Fair 2023: Converging Rare Disease Stakeholders
From September 7-9, 2023, the Rare Fair was held in Research Triangle Park, North Carolina, and was also available for attendance online. This event began
FDA Advisory Committee Votes Against Approving NurOwn for ALS
According to a recent BioSpace article from Heather McKenzie, the U.S. Food and Drug Administration’s Cellular, Tissue, and Gene Therapies Advisory Committee recently voted
